Change in Management

Ref: ADL/SE/2026-27/50 September 30, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sub: Changes in the Directorate/ Management Pursuant to the outcome of the Board meeting dated July 31, 2026 and approval of the shareholders in 41st Annual General Meeting dated September 26, 2026, kindly take the note of following changes in the Directorate and Key Managerial Personnel of the Company: A) Cessation of Shri Prakash M. Patil from the positions of Chairman, Managing Director and Chief Executive Officer With reference to the earlier intimation bearing reference no. ADL/SE/2026-27/28 dated July 31, 2026, regarding the decision of Shri Prakash M. Patil to take early retirement and resign from the positions of Chairman, Managing Director and Chief Executive Officer of the Company, we hereby inform that he has ceased to hold the aforesaid positions with effect from the close of business hours on September 30, 2026. A copy of the letter received from Shri Prakash M. Patil communicating his decision in this regard is enclosed herewith as Annexure-II. B) Relinquishment of office of Chief Financial Officer by Shri Adhish P. Patil Pursuant to the approval of the Members of the Company at the 41st Annual General Meeting held on September 26, 2026, Shri Adhish P. Patil has been promoted to the position of Managing Director of the Company with effect from October 1, 2026. Consequently, Shri Adhish P. Patil has relinquished the position of Chief Financial Officer of the Company with effect from the close of business hours on September 30, 2026. A copy of the letter received from Shri Adhish P. Patil communicating his decision in this regard is enclosed herewith as Annexure-III. The Company will appoint a Chief Financial Officer in due course, in compliance with Regulation 26A(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The required details pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as Annexure-I. Kindly take the same on record. Thanking you Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. No.: F12932 Annexure – I Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III and SEBI Circular SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Sr. Particulars Shri Prakash M. Patil Shri Adhish P. Patil No. (DIN: 00005618) 1. Reason for change Cessation from the positions of Relinquishment of the position of viz. appointment, re- Chairman, Managing Director Chief Financial Officer appointment, and Chief Executive Officer of consequent upon his promotion resignation, removal, the Company pursuant to his (appointment) as Managing death or otherwise; desire to take early retirement. Director of the Company 2. date of with effect from the close of with effect from the close of appointment/re- business hours on September business hours on September appointment/cessation 30, 2026 30, 2026 (as applicable) & term of appointment/re- appointment; 3. Brief Profile (in case Not Applicable Not Applicable of appointment); 4. disclosure of Not Applicable Not Applicable relationships between directors (in case of appointment of a director). Annexure-II Annexure-III ADHISH PRAKASH PATIL September 26, 2026 The Board of Directors AARTI DRUGS LIMITED Plot No. N-198, MIDC Tarapur, Village Pamtermbhi, Tal And Dist. Palghar 401506. Subject: Relinquishment of the position of Chief Financial Officer Dear Sir/Madam, I, Shri Adhish P. Patil, hereby inform that pursuant to the approval of the Members of the Company at the 41st Annual General Meeting held on September 26, 2026, I have been appointed as the Managing Director of the Company with effect from October 1, 2026. Consequent to my appointment as the Managing Director of the Company, I hereby relinquish the position of Chief Financial Officer (CFO) of the Company with effect from the close of business hours on September 30, 2026. I shall continue to support and oversee the functions under the purview of CFO along with my responsibilities as the Managing Director of the Company. Thanking you, Yours faithfully, ADHISH PRAKASH PATIL